eFFECTOR Therapeutics
EFTR
#9698
Rank
NZ$0.32 M
Marketcap
$0.06870
Share price
-5.56%
Change (1 day)
-99.69%
Change (1 year)

Revenue for eFFECTOR Therapeutics (EFTR)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for eFFECTOR Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A